Europe To Resume AZ Vaccine Use After Safety Review, But Confidence Knocked

Rare But Serious Events Being Monitored

The EMA’s conclusions are in line with those of the UK regulator and the World Health Organization, but EU countries’ stop-start decisions will have done nothing to boost the public’s trust in the vaccine.

Italy vaccinations
Turin, Italy: vaccinations with the Pfizer/BioNTech and Moderna shots have continued across the EU, but the AZ vaccine is needed to meet demand. • Source: Getty Images

Countries in the European Union which had suspended use of AstraZeneca’s COVID-19 vaccine will resume after the bloc’s medicines regulator gave it the all clear.

The European Medicine Agency’s preliminary review concluded that the vaccine remained safe and effective at protecting against the “significant threat”...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography